{"transactions":[{"id":710103,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-14T20:18:54.000Z","date":"2026-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":14041,"price":4.26,"value":59814.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":198417,"source":{"system":"sec-edgar","filing":"0001104659-26-083516","document":"tm2620483-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926083516/tm2620483-1_4seq1.xml","form_type":"4"}},{"id":839633,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-17T23:46:39.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4919,"price":10.54,"value":51846.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":212458,"source":{"system":"sec-edgar","filing":"0001104659-26-029711","document":"tm269075-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926029711/tm269075-1_4seq1.xml","form_type":"4"}},{"id":849500,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-03-12T01:15:03.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":421226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the Stock Options shall vest on March 9th of each of 2027, 2028, 2029, and 2030, in each case subject to continuous service through the applicable vesting date."}],"balance_after":421226,"derivative":{"exercise_price":11.61,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":421226},"source":{"system":"sec-edgar","filing":"0001104659-26-026582","document":"tm268588-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926026582/tm268588-7_4seq1.xml","form_type":"4"}},{"id":1088220,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-14T20:05:21.000Z","date":"2025-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":13637,"price":2.27,"value":30955.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":217377,"source":{"system":"sec-edgar","filing":"0001104659-25-067746","document":"tm2520709-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925067746/tm2520709-1_4seq1.xml","form_type":"4"}},{"id":1165971,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-25T20:07:12.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":6061,"price":1.95,"value":11818.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":231014,"source":{"system":"sec-edgar","filing":"0001104659-25-039417","document":"tm2513168-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925039417/tm2513168-3_4seq1.xml","form_type":"4"}},{"id":1165970,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-25T20:07:12.000Z","date":"2024-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":22925,"price":2.68,"value":61439.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":237075,"source":{"system":"sec-edgar","filing":"0001104659-25-039417","document":"tm2513168-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925039417/tm2513168-3_4seq1.xml","form_type":"4"}},{"id":1279277,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-07T21:15:15.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the Stock Options shall vest on February 5th of each of 2026, 2027, 2028, and 2029, in each case subject to continuous service through the applicable vesting date."}],"balance_after":240000,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001104659-25-010550","document":"tm255864-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925010550/tm255864-1_4seq1.xml","form_type":"4"}},{"id":1573476,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-19T00:00:18.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the Stock Options shall vest on March 14th of each of 2025, 2026, 2027, and 2028."}],"balance_after":240000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001104659-24-035723","document":"tm249071-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035723/tm249071-1_4seq1.xml","form_type":"4"}},{"id":1573475,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-19T00:00:18.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":260000,"source":{"system":"sec-edgar","filing":"0001104659-24-035723","document":"tm249071-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465924035723/tm249071-1_4seq1.xml","form_type":"4"}},{"id":1700426,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-27T02:53:29.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the Stock Options shall vest on July 10th of each of 2024, 2025, 2026, and 2027."}],"balance_after":200000,"derivative":{"exercise_price":2.39,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-23-129365","document":"tm2333426-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465923129365/tm2333426-7_4seq1.xml","form_type":"4"}},{"id":1700425,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-27T02:53:29.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001104659-23-129365","document":"tm2333426-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465923129365/tm2333426-7_4seq1.xml","form_type":"4"}},{"id":1880197,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2023-05-24T21:56:18.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2023 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":13.64,"exercise_date":"2024-05-22","expiration_date":"2033-05-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-064214","document":"tm2316873-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465923064214/tm2316873-5_4seq1.xml","form_type":"4"}},{"id":1880196,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T21:56:18.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":16495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2023 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":58984,"source":{"system":"sec-edgar","filing":"0001104659-23-064214","document":"tm2316873-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000110465923064214/tm2316873-5_4seq1.xml","form_type":"4"}},{"id":2289881,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-statutory Stock Option","published_at":"2022-04-27T22:53:19.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2022 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":17.79,"exercise_date":"2023-04-25","expiration_date":"2032-04-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001567619-22-009046","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761922009046/doc1.xml","form_type":"4"}},{"id":2289880,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-27T22:53:19.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":12647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") and options upon the conclusion of the Issuer's 2022 annual meeting of stockholders. 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":42489,"source":{"system":"sec-edgar","filing":"0001567619-22-009046","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761922009046/doc1.xml","form_type":"4"}},{"id":2703787,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-21T00:13:24.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":17482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\") upon the conclusion of the Issuer's 2021 annual meeting of stockholders. 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":29842,"source":{"system":"sec-edgar","filing":"0001567619-21-010826","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761921010826/doc1.xml","form_type":"4"}},{"id":2768403,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-30T21:38:59.000Z","date":"2021-03-29","kind":"grant","acquired":true,"shares":1612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or March 9, 2022, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date."}],"balance_after":12360,"source":{"system":"sec-edgar","filing":"0001567619-21-007206","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761921007206/doc1.xml","form_type":"4"}},{"id":2773556,"issuer":{"id":4679,"kind":"organization","name":"Innoviva, Inc."},"owners":[{"id":30633,"kind":"person","name":"Birx Deborah","position":1,"cik":"0001849673","reported_name":"Birx Deborah","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-24T20:45:03.000Z","date":"2021-03-22","kind":"grant","acquired":true,"shares":10748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-half of the restricted stock units will vest on March 9, 2022, and the remainder will vest on March 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-half of the restricted stock units will vest on March 9, 2022, and the remainder will vest on March 9, 2023."}],"balance_after":10748,"derivative":{"underlying":"Common Stock","underlying_shares":10748},"source":{"system":"sec-edgar","filing":"0001567619-21-006868","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1080014/000156761921006868/doc1.xml","form_type":"4"}}]}